Cost-effectiveness of prophylactic antibiotic use to prevent catheter-associated urinary tract infections

被引:3
作者
Wang, Rui [1 ]
Hacker, Michele R. [1 ,2 ,3 ]
Lefevre, Roger [1 ,2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Obstet, Gynecology, 330 Brookline Ave, Kirstein 3, Boston, MA 02215 USA
[2] Harvard Med Sch, Dept Obstet, Gynecology, Reprod Biol, Boston, MA 02115 USA
[3] Chan Sch Publ Hlth, Dept Epidmiol, Harvard T, Boston, MA 02115 USA
关键词
Costs and cost analysis; Cost-benefit analysis; Antibiotic prophylaxis; Urinary tract infections; Catheter-related infections;
D O I
10.1007/s00192-019-04034-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose We evaluate the cost-effectiveness of prophylactic antibiotic use to prevent catheter-associated urinary tract infections. Materials and methods A decision tree model was used to assess the cost-effectiveness of prophylactic antibiotics in preventing catheter-associated urinary tract infections for patients with a short-term indwelling urinary catheter. The model accounted for incidence of urinary tract infections with and without the use of prophylactic antibiotics, incidence of antibiotic-resistant urinary tract infections, as well as costs associated with diagnosis and treatment of urinary tract infections and antibiotic-resistant urinary tract infections. Costs were calculated from the health care system's perspective. We conducted one-way sensitivity analyses. Results The base case analysis showed that the use of prophylactic antibiotics is cost-saving in preventing catheter-associated urinary tract infections. The use of prophylactic antibiotics resulted in lower costs and higher quality-adjusted life-years compared with no prophylactic antibiotics. Sensitivity analyses showed that the optimal strategy changes to no prophylactic antibiotics when the incidence of urinary tract infections after prophylactic antibiotics exceeds 22% or the incidence of developing urinary tract infections without prophylactic antibiotics is less than 12%. Varying the costs of prophylactic antibiotics, urinary tract infection treatment, or antibiotic-resistant urinary tract infection treatment within a reasonable range did not change the optimal strategy. Conclusions Prophylactic antibiotic use to prevent catheter-associated urinary tract infections is cost-effective under most conditions. These results were sensitive to the likelihood of developing catheter-associated urinary tract infections with and without prophylactic antibiotics. Our results are limited to the cost-effectiveness perspective on this clinical practice.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 15 条
  • [1] Barry HC, 1997, J FAM PRACTICE, V44, P49
  • [2] Intermittent self catheterisation with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysis
    Bermingham, Sarah L.
    Hodgkinson, Sarah
    Wright, Sue
    Hayter, Ellie
    Spinks, Julian
    Pellowe, Carol
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [3] AN EVALUATION OF DAILY BACTERIOLOGIC MONITORING TO IDENTIFY PREVENTABLE EPISODES OF CATHETER-ASSOCIATED URINARY-TRACT INFECTION
    GARIBALDI, RA
    MOONEY, BR
    EPSTEIN, BJ
    BRITT, MR
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1982, 3 (06) : 466 - 470
  • [4] CATHETER-ASSOCIATED URINARY-TRACT INFECTIONS IN SURGICAL PATIENTS - A CONTROLLED-STUDY ON THE EXCESS MORBIDITY AND COSTS
    GIVENS, CD
    WENZEL, RP
    [J]. JOURNAL OF UROLOGY, 1980, 124 (05) : 646 - 648
  • [5] The Economic Effect of Screening Orthopedic Surgery Patients Preoperatively for Methicillin-Resistant Staphylococcus aureus
    Lee, Bruce Y.
    Wiringa, Ann E.
    Bailey, Rachel R.
    Goyal, Vishal
    Tsui, Becky
    Lewis, G. Jonathan
    Muder, Robert R.
    Harrison, Lee M.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (11) : 1130 - 1138
  • [6] Universal Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance for Adults at Hospital Admission: An Economic Model and Analysis
    Lee, Bruce Y.
    Bailey, Rachel R.
    Smith, Kenneth J.
    Muder, Robert R.
    Strotmeyer, Elsa S.
    Lewis, G. Jonathan
    Ufberg, Paul J.
    Song, Yeohan
    Harrison, Lee H.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (06) : 598 - 606
  • [7] Staphylococcus aureus vaccine for orthopedic patients: An economic model and analysis
    Lee, Bruce Y.
    Wiringa, Ann E.
    Bailey, Rachel R.
    Lewis, G. Jonathan
    Feura, Jared
    Muder, Robert R.
    [J]. VACCINE, 2010, 28 (12) : 2465 - 2471
  • [8] Antibiotic prophylaxis for short-term catheter bladder drainage in adults
    Lusardi, Gail
    Lipp, Allyson
    Shaw, Christine
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (07):
  • [9] Multistate Point- Prevalence Survey of Health Care- Associated Infections
    Magill, Shelley S.
    Edwards, Jonathan R.
    Bamberg, Wendy
    Beldavs, Zintars G.
    Dumyati, Ghinwa
    Kainer, Marion A.
    Lynfield, Ruth
    Maloney, Meghan
    McAllister-Hollod, Laura
    Nadle, Joelle
    Ray, Susan M.
    Thompson, Deborah L.
    Wilson, Lucy E.
    Fridkin, Scott K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (13) : 1198 - 1208
  • [10] Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis
    Marschall, Jonas
    Carpenter, Christopher R.
    Fowler, Susan
    Trautner, Barbara W.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346